APA (7th ed.) Citation

SZ, Z., H, L., ZW, W., MH, W., N, L., & YF, W. (2020). LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway. Cell cycle (Georgetown, Tex.), 19(21), 2776. https://doi.org/10.1080/15384101.2020.1820697

Chicago Style (17th ed.) Citation

SZ, Zhou, Li H, Wang ZW, Wang MH, Li N, and Wang YF. "LncRNA TSLNC8 Synergizes with EGFR Inhibitor Osimertinib to Inhibit Lung Cancer Tumorigenesis by Blocking the EGFR-STAT3 Pathway." Cell Cycle (Georgetown, Tex.) 19, no. 21 (2020): 2776. https://doi.org/10.1080/15384101.2020.1820697.

MLA (9th ed.) Citation

SZ, Zhou, et al. "LncRNA TSLNC8 Synergizes with EGFR Inhibitor Osimertinib to Inhibit Lung Cancer Tumorigenesis by Blocking the EGFR-STAT3 Pathway." Cell Cycle (Georgetown, Tex.), vol. 19, no. 21, 2020, p. 2776, https://doi.org/10.1080/15384101.2020.1820697.